Walgreens Boots Alliance (NASDAQ:WBA) Trading Down 1% – Time to Sell?

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) traded down 1% during mid-day trading on Monday . The stock traded as low as $10.45 and last traded at $10.68. 4,681,603 shares were traded during trading, a decline of 73% from the average session volume of 17,092,639 shares. The stock had previously closed at $10.79.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Finally, UBS Group increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $13.38.

View Our Latest Research Report on WBA

Walgreens Boots Alliance Price Performance

The stock’s fifty day moving average price is $9.41 and its two-hundred day moving average price is $13.06. The firm has a market capitalization of $9.15 billion, a price-to-earnings ratio of -1.07, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70. The company has a current ratio of 0.68, a quick ratio of 0.31 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period last year, the business earned $0.67 EPS. The company’s revenue was up 5.9% on a year-over-year basis. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.57 EPS for the current year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Hedge funds and other institutional investors have recently bought and sold shares of the stock. New Covenant Trust Company N.A. acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth $35,000. Iron Horse Wealth Management LLC increased its stake in Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the period. FinTrust Capital Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 60.4% in the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 802 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the period. Finally, Continuum Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.